Skip to main content
All lobbying filings

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) filed a Q4 amendment for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) on April 20, 2026.

Lobbying for THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES)

All filings by THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) · Everything THE CIGNA GROUP AND SUBSIDIARIES (FORMERLY CIGNA CORPORATION AND SUBSIDIARIES) has reported

 Filing · LD-2 quarterly report Q4 amendment
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Apr 20, 2026
Expenses
$1,670,000
What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.
Client based in
District of Columbia

Official filing document

 Government bodies contacted 4

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 5
Medicare/Medicaid

Issues related to prior authorization.

Health Issues

S. 864/H.R. 247, the Health Care Affordability Act of 2025 and issues relating to extension of Enhanced Advanced Premium Tax Credits (EAPTCs) including in the American Rescue Plan Act (ARPA) and the Inflation Reduction Act (IRA); Issues relating to implementation of the No Surprises Act.

Defense

H.R. 3838/S. 2296 Pharmacy issues related to the National Defense Authorization Act, FY2026.

Pharmacy

"S. 1542/H.R.2214, the DRUG Act; H.R. 5378 Lower Costs, More Transparency Act; S. 1339, Pharmacy Benefit Manager Reform Act; S.526, Pharmacy Benefit Manager Transparency Act." Issues related to the specialty drug market. Issues related to transparency.

Labor Issues/Antitrust/Workplace

Issues related to competition in the health care marketplace.

 Bills named in this filing 9
  • S. 864
    HELP Copays Act
  • H.R. 247
    Health Care Affordability Act of 2025
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
  • S. 1542
    DRUG Act
  • H.R. 2214
    DRUG Act
  • H.R. 5378
    Lower Costs, More Transparency Act
  • S. 1339
    Pharmacy Benefit Manager Reform Act
  • S. 526
    Pharmacy Benefit Manager Transparency Act of 2025

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem